122 related articles for article (PubMed ID: 11026054)
1. [Chemosensitivity test of breast cancer].
Oura S; Tanino H; Naito Y
Nihon Rinsho; 2000 Apr; 58 Suppl():581-6. PubMed ID: 11026054
[No Abstract] [Full Text] [Related]
2. Synthesis of taxoids with improved cytotoxicity and solubility for use in tumor-specific delivery.
Miller ML; Roller EE; Zhao RY; Leece BA; Ab O; Baloglu E; Goldmacher VS; Chari RV
J Med Chem; 2004 Sep; 47(20):4802-5. PubMed ID: 15369381
[TBL] [Abstract][Full Text] [Related]
3. Correlation of in vitro cytotoxicity and clinical response to chemotherapy in ovarian and breast cancer patients.
Agiostratidou G; Sgouros I; Galani E; Voulgari A; Chondrogianni N; Samantas E; Dimopoulos MA; Skarlos D; Gonos ES
Anticancer Res; 2001; 21(1A):455-9. PubMed ID: 11299779
[TBL] [Abstract][Full Text] [Related]
4. [Efficacy of docetaxel for recurrent breast cancer: evaluation based on chemosensitivity test and clinical response].
Sakurai T; Tanino H; Oura S; Suzuma T; Yamamiti N; Yoshimasu T; Sakurai T; Naito Y
Gan To Kagaku Ryoho; 2000 Mar; 27(3):423-7. PubMed ID: 10740636
[TBL] [Abstract][Full Text] [Related]
5. Heterogeneity of drug resistance in human breast and ovarian cancers.
Kern DH
Cancer J Sci Am; 1998; 4(1):41-5. PubMed ID: 9467045
[TBL] [Abstract][Full Text] [Related]
6. Anticancer chemosensitivity profiles of human breast cancer cells assessed by in vitro DNA synthesis inhibition assay.
Nio Y; Tamura K; Kan N; Inamoto T; Ohgaki K; Kodama H
Anticancer Res; 2000; 20(2B):1237-44. PubMed ID: 10810427
[TBL] [Abstract][Full Text] [Related]
7. Antitumor activity of doxorubicin in combination with docetaxel against human breast cancer xenografts.
Egawa T; Kubota T; Suto A; Otani Y; Furukawa T; Saikawa Y; Watanabe M; Kumai K; Kitajima M
In Vivo; 2003; 17(1):23-8. PubMed ID: 12655785
[TBL] [Abstract][Full Text] [Related]
8. [Chemosensitivity test for 170 human breast carcinoma samples].
He Z; Yuan J; Chen Z; Liu S; Shen Z; Fei H
Hunan Yi Ke Da Xue Xue Bao; 1998; 23(6):531-4. PubMed ID: 10806759
[TBL] [Abstract][Full Text] [Related]
9. Chemosensitivity of breast cancer lymph node metastasis compared to the primary tumor from individual patients tested in the histoculture drug response assay.
Furukawa T; Kubota T; Tanino H; Oura S; Yuasa S; Murate H; Morita K; Kozakai K; Yano T; Hoffman RM
Anticancer Res; 2000; 20(5C):3657-8. PubMed ID: 11268434
[TBL] [Abstract][Full Text] [Related]
10. [Predicting clinical chemo-sensitivity of primary ovarian cancer using adenosine triphosphate-tumor chemosensitivity assay combined with detection of drug resistance genes].
Zhao D; Zhang W; Li XG; Wang XB; Zhang LF; Li M; Li YF; Tian HM; Song PP; Liu J; Chang QY; Wu LY
Zhonghua Fu Chan Ke Za Zhi; 2011 Mar; 46(3):193-8. PubMed ID: 21575453
[TBL] [Abstract][Full Text] [Related]
11. Gef gene therapy enhances the therapeutic efficacy of doxorubicin to combat growth of MCF-7 breast cancer cells.
Prados J; Melguizo C; Rama AR; Ortiz R; Segura A; Boulaiz H; Vélez C; Caba O; Ramos JL; Aránega A
Cancer Chemother Pharmacol; 2010 May; 66(1):69-78. PubMed ID: 19771430
[TBL] [Abstract][Full Text] [Related]
12. [Collagen gel droplet-embedded culture drug sensitivity test in human breast cancer].
Yamamoto Y; Watanabe Y; Ishida N; Hidaka T; Sugishita H; Yoshida M; Yukumi S; Sato K; Nakagawa H; Horiuchi A; Kawachi K
Gan To Kagaku Ryoho; 2008 May; 35(5):793-6. PubMed ID: 18487915
[TBL] [Abstract][Full Text] [Related]
13. Synthesis and structure-activity relationships of nonaromatic taxoids: effects of alkyl and alkenyl ester groups on cytotoxicity.
Ojima I; Kuduk SD; Pera P; Veith JM; Bernacki RJ
J Med Chem; 1997 Jan; 40(3):279-85. PubMed ID: 9022794
[TBL] [Abstract][Full Text] [Related]
14. [Chemosensitivity test-based chemotherapy for brain tumors].
Fujimoto S
Nihon Rinsho; 2005 Sep; 63 Suppl 9():456-9. PubMed ID: 16201564
[No Abstract] [Full Text] [Related]
15. Antisense Bcl-2 and HER-2 oligonucleotide treatment of breast cancer cells enhances their sensitivity to anticancer drugs.
Tanabe K; Kim R; Inoue H; Emi M; Uchida Y; Toge T
Int J Oncol; 2003 Apr; 22(4):875-81. PubMed ID: 12632082
[TBL] [Abstract][Full Text] [Related]
16. Inhibitory effects of combinations of HER-2/neu antibody and chemotherapeutic agents used for treatment of human breast cancers.
Pegram M; Hsu S; Lewis G; Pietras R; Beryt M; Sliwkowski M; Coombs D; Baly D; Kabbinavar F; Slamon D
Oncogene; 1999 Apr; 18(13):2241-51. PubMed ID: 10327070
[TBL] [Abstract][Full Text] [Related]
17. Erythropoietin fails to interfere with the antiproliferative and cytotoxic effects of antitumor drugs.
Gewirtz DA; Di X; Walker TD; Sawyer ST
Clin Cancer Res; 2006 Apr; 12(7 Pt 1):2232-8. PubMed ID: 16609039
[TBL] [Abstract][Full Text] [Related]
18. In vitro chemosensitivity in breast cancer using ATP-tumor chemosensitivity assay.
Qi CJ; Ning YL; Zhu YL; Min HY; Ye H; Qian KQ
Arch Pharm Res; 2009 Dec; 32(12):1737-42. PubMed ID: 20162402
[TBL] [Abstract][Full Text] [Related]
19. In vitro chemosensitivity testing of primary and recurrent breast carcinomas and its clinical significance.
Li Z; Song H; He W; Tian Y; Huang T
J Huazhong Univ Sci Technolog Med Sci; 2008 Dec; 28(6):683-7. PubMed ID: 19107367
[TBL] [Abstract][Full Text] [Related]
20. In vitro drug resistance versus chemosensitivity: two sides of different coins.
Fruehauf JP; Alberts DS
J Clin Oncol; 2005 May; 23(15):3641-3; author reply 3646-8. PubMed ID: 15908686
[No Abstract] [Full Text] [Related]
[Next] [New Search]
